REGISTERED
on 13 Oct 2020
Last Applicant/ Owned by
55131 Mainz
DE
Serial Number
79268012 filed on 06th Aug 2019
Registration Number
6171861 registered on 13th Oct 2020
Correspondent Address
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
10th Floor
Washington, DC 20005
United States
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
RIBOTECT
Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions Medical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and m Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79268012
Mark Type
No Service Mark
Attorney Docket Number
No 3814.1000000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th May 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 30th May 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 30th May 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 30th May 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 30th May 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 30th May 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 19th Nov 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 20th Feb 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 29th Jan 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| 29th Jan 2021 | FINAL DISPOSITION PROCESSED |